Jane Street’s Therapix Biosciences Ltd. TRPX Stock Holding History

Jane Street’s Portfolio TRPX Stock Details TRPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,914	Closed	-$77K	–	5424
2017 Q3	$77K	Sell	12,914 -241	-2%	-$1.44K	﹤0.01%	4300
2017 Q2	$92K	Buy	+13,155	New	+$91.5K	﹤0.01%	4174

Other funds holding TRPX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Jane Street's TRPX Position: Q4 2017 in Review

Jane Street sold out of Therapix Biosciences Ltd. (TRPX) in Q4 2017, closing a stake of 12,914 shares — an estimated $77K sold.

Jane Street first reported a position in TRPX in Q2 2017 and held it in 2 quarters. The position peaked at $92K in Q2 2017. 5 funds tracked by Wall St. Rank hold TRPX as of Q4 2017.

Jane Street reported no remaining Therapix Biosciences Ltd. position as of Q4 2017 after selling out during the quarter.
Jane Street sold 12,914 Therapix Biosciences Ltd. shares in Q4 2017, an estimated $77K.
Jane Street first reported a position in Therapix Biosciences Ltd. in Q2 2017 and held it in 2 quarters.
Jane Street's Therapix Biosciences Ltd. position peaked at $92K in Q2 2017.
5 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q4 2017.

Based on Jane Street's 13F filing for Q4 2017, filed 15 Feb 2018.